These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [An abdominal CT scan in first-line is an efficient investigation of uncontrolled hypertensives suspected to have an adrenal cause]. Rosenbaum D; Rigabert J; Villeneuve F; Girerd X Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):209-12. PubMed ID: 22748398 [TBL] [Abstract][Full Text] [Related]
3. [Adrenal cortex scintigraphy with and without dexamethasone suppression in the study of primary aldosteronism]. Milà López M; Castell-Conesa J; Pifarré Montaner P; Lorenzo Bosquet C; García-Burillo A; Porta Biosca F; Roca Bielsa I Rev Esp Med Nucl; 2004; 23(5):324-9. PubMed ID: 15450137 [TBL] [Abstract][Full Text] [Related]
4. Limited significance of asymmetric adrenal visualization on dexamethasone-suppression scintigraphy. Gross MD; Shapiro B; Freitas JE J Nucl Med; 1985 Jan; 26(1):43-8. PubMed ID: 2981301 [TBL] [Abstract][Full Text] [Related]
5. Interference by spironolactone on adrenocortical scintigraphy and other pitfalls in the location of adrenal abnormalities in primary aldosteronism. Shapiro B; Grekin R; Gross MD; Freitas JE Clin Nucl Med; 1994 May; 19(5):441-5. PubMed ID: 8039321 [TBL] [Abstract][Full Text] [Related]
6. Adrenal scintigraphy in primary aldosteronism. Spironolactone as a cause of incorrect classification between adenoma and hyperplasia. Fischer M; Vetter W; Winterg B; Zidek W; Vetter H Eur J Nucl Med; 1982; 7(5):222-4. PubMed ID: 7094925 [TBL] [Abstract][Full Text] [Related]
15. [Computer tomographic localisation in primary aldosteronism. Comparison with adrenal scintigraphy (author's transl)]. Galanski M; Fischer M; Cramer BM; Friemann J; Vetter H Rofo; 1980 Dec; 133(6):629-33. PubMed ID: 6453793 [TBL] [Abstract][Full Text] [Related]
16. Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour. Ferriss JB; Brown JJ; Fraser R; Kay AW; Neville AM; O'Muircheartaigh IG; Robertson JI; Symington T; Lever AF Lancet; 1970 Nov; 2(7681):995-1000. PubMed ID: 4098088 [No Abstract] [Full Text] [Related]
17. False localization of an aldosteronoma by dexamethasone-suppressed adrenal scintigraphy. Herd GW; Semple PF; Parker D; Davidson JK; Hilditch TE; Fraser R Clin Endocrinol (Oxf); 1987 Jun; 26(6):699-705. PubMed ID: 3665124 [TBL] [Abstract][Full Text] [Related]
18. Primary aldosteronism: a noninvasive procedure for tumor localization as well as for distinction from bilateral hyperplasia. Conn JW; Cohen EL; Herwig KR Adv Nephrol Necker Hosp; 1977; 7():137-56. PubMed ID: 96670 [No Abstract] [Full Text] [Related]
19. [Adrenal scintigraphy using 131I-adosterol--as to the usefulness of dexamethasone suppression scintigraphy (author's transl)]. Fukunaga M; Dokoh S; Yamamoto I; Morita R; Torizuka K; Fujita T; Kono T; Tanimura H; Shinpo S Radioisotopes; 1977 Dec; 26(12):864-8. PubMed ID: 605223 [No Abstract] [Full Text] [Related]
20. The value of scintigraphy and computed tomography for the differential diagnosis of primary hyperaldosteronism. Hietakorpi S; Korhonen T; Aro A; Lampainen E; Alhava E; Karjalainen P; Wiljasalo S Acta Endocrinol (Copenh); 1986 Sep; 113(1):118-22. PubMed ID: 3766043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]